Role of predictors and rapid diagnosis of fungal peritonitis in CAPD patients
DOI:
https://doi.org/10.18203/2349-3933.ijam20160204Keywords:
Fungal peritonitis, End stage renal disease, CAPD, Predictors, Candida albicans, Non albicansAbstract
Background: Fungal peritonitis represents one of the most serious complications in patients on CAPD therapy. In the present study we analyze PD patients who developed fungal peritonitis.
Methods: In between January 2000 to August 2015, we retrospectively identified fungal PD peritonitis episodes, examined the demographic features, incidence, predictors, causative fungi and outcome.
Results: We analyzed 65 episodes of PD associated fungal peritonitis which includes 89.3% Candida species, 1.5% yeast and 9.2% dimorphic fungi. Association between predictors and pathogens was found significant at 0.05 levels. Catheter removal (47.1%) and loss of life (20.6%) was significantly more frequent in patients with diabetes, glomerulonephritis required maximum hospitalization while cure rate (55.6%) was more significant in patients with hypertension. Data were significant at p value of 0.05.
Conclusions: Our results suggest that prompt identification of predictors may force us for early intervention to reduce mortality and technique failure in PD associated fungal peritonitis. Early availability of direct microscopy of dialysate pellet became useful for the rapid, aggressive and judicious management of the fungal peritonitis and was the reason of high cure (27.7%) and low mortality (15.7%) in our case series.
References
Rowinska JM. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009;29(2):S161-5.
Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005;25:207-22.
Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M. Fungal peritonitis complicating peritoneal dialysis during an 11-Year Period: Report of 46 Cases. Clin Infect Dis. 2003;36:927-31.
Agudo RG, Martos PG. Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis. Nefrologia. 2009;29(6):506-17.
Kumar KV, Mallikarjuna HM, Gokulnath, Jayanthi S. Fungal peritonitis in continuous ambulatory peritoneal dialysis: The impact of antifungal prophylaxis on patient and technique outcomes. Indian J Nephrol. 2014;24(5):297-301.
Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2010 Update. Perit Dial Int. 2010;30:393-423.
Michel C, Courdavault L, Khayat RA, Viron B, Roux P, Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol. 1994;14:113-20.
Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009;76:622-8.
Piraino B. Peritonitis as complication of peritoneal dialysis. J Am Soc Nephrol. 1998;9:1956-64.
Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis. 1998;17:839-43.
Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial. 2003;6:428-37.
Molina P, Puchades MJ, Aparicio M, Ramón RG, Miguel A. Experiencia en peritonitis fúngica en una unidad de diálisis durante diez años. Nefrología. 2005;25:393-8.
Kocak Z, Bulut C, Kinikli S, Yilmaz GR, Irmak H, Demdroz AP. Fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of three cases. Turk Med J. 2007;1:30-3.
Liu SW, Chern CH, Yen DH, Huang CI, How CK. Abdominal wall and intraperitoneal abscesses complicating Aspergillus peritonitis in peritoneal dialysis. Am J Med Sci. 2009;337:56.
The Turkish multicenter peritoneal dialysis study group (TULIP). The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: experience in Turkey. Perit Dial Int. 2000;20:338-40.
Chen CM, Ho MW, Yu WL, Wang JH. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. J Microbiol Immunol Infect. 2004;37:115-20.
Felgueiras J, Peso GD, Bajo A, Hevia C, Romero S, Celadilla O, et al. Risk of technique failure and death in fungal peritonitis is determined mainly by duration on peritoneal dialysis: single-center experience of 24 years. Adv Perit Dial. 2006;22:77-81.
Predari SC, De Paulis AN, Verón D, Zucchini A, Santoianni JE. Fungal peritonitis in patients on peritoneal dialysis: twenty five years of experience in a teaching hospital in Argentina. Rev Argent Microbiol. 2007;39:213-7.
Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. ISPD guidelines/recommendations. Peritoneal dialysis related infections: 2005 Update. Perit Dial Int. 2005;25:107-31.
Indhumathi E, Chandrasekaran V, Jagadeswaran D, Varadarajan M, Abraham G, Soundararajan P. The risk factors and outcome of fungal peritonitis in continuous ambulatory peritoneal dialysis patients. Indian J Med Microbiol. 2009;27:59-61.
Cheng IKP, Fang GX, Chan TM, Chan PCK, Chan MK. Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. Q J Med. 1989;265:407-16.
Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 Update. Perit Dial Int. 2000;20:396-411.
Fourtounas C, Marangos M, Kalliakmani P, Savidaki E, Goumenos DS, Vlachojannis JG. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant. 2006;21:236-7.
